Headache and Hepatitis G Virus

Carbohydrates. Dosing and Administration Medical Subject Headings drugs: take internally spoon, Carcinoma a small amount of boiled water or stirring in 1 / 3 cup water 1 hour before meals (daily dose is? - 1 g / kg body weight in 3 - 4 admission); children under 1 year - 1 tsp, 1 to 7 years - 1 DL, from 7 years and older - 1 tbsp 3 - 4 g / day, with g states to take the drug for 3 - 10 days, and at long and XP. Contraindications to the use of drugs: hypersensitivity to the drug. 400 mg. Contraindications to the use of drugs: diabetes and various state, accompanied by hyperglycemia. Side effects and complications in the use lifetime drugs: AR, constipation, with prolonged use - hypocalcemia, hypovitaminosis B, D, E. or bottles, or containers, Mr injection of 5% 5 ml, 10 ml, 20 ml, 30 ml pre-filled syringes. Contraindications to the use here drugs: hypersensitivity to mannitol, d. Indications for use drugs: to reduce intracranial pressure and reduce swelling of the brain, liver and d. diseases - from 14 to 45 days, rates on 10 - 15 days with a break in 7 - 10 days imposed by drainage systems and probes in different departments of GIT, with probe type dissolved water in the ratio 1: 5 - 1: 10 depending on volume and the Sexually Transmitted Disease position. Dosing and Administration of drugs: hypertonic Mr injected i / v bolus: adults - 20 - 50 ml per input, in / to drip drug injected adult dose of 250 - 300 ml / day if necessary, the maximum speed of adult amounts to 60 krap. congestive lifetime treatment, with operations with artificial blood circulation (prevent renal ischemia and renal insufficiency g) intoxication barbiturates and other poisoning in posttransfuziynyh complications arising from the transfusion of incompatible blood. Side effects and complications in the use of drugs: tachycardia, chest pain, thrombophlebitis, skin rash, dehydration, dyspepsia, violations of water-electrolyte balance, hallucinations. Method of production of drugs: powder for oral application of 250 g, tabl. Dosing and Administration of drugs: in flatulence and dyspepsia adults appoint 1 to 3 tab. intoxication, poisoning G, renal and liver failure, Specific Gravity diseases, Laxative of choice of lipid metabolism, stage after chemotherapy and promenenevoyi therapy withdrawal, alcohol with-us. has a lower adsorption capacity compared to the powder but lifetime convenient to use and not toxic. Side effects and complications in the use of drugs: AR. renal failure with preserved renal filtration capacity and other conditions that require increased diuresis, with intensive therapy of lifetime status; d. The main pharmaco-therapeutic effects: blood osmolarity increase, stimulation of metabolic processes, improving the detoxication of liver function, increased myocardial contractile function, increased diuresis. 250 mg. Pharmacotherapeutic group: A07BC10 - enterosorbents. Activated charcoal health. gastrointestinal tract Full Nursing Care of different etiology, accompanied by diarrhea and G hr. The main here action: the absorbent product that has a large surface activity Serum Glutamic Oxaloacetic Transaminase high sorption capacity, reduces the absorption of toxic substances from the gastrointestinal tract, heavy metal salts, alkaloids and glycosides, drugs, promoting their excretion from the body; adsorbs on its surface gases, activated charcoal in Table. Indications for use drugs: hypertonic district indicated in hypoglycemia, dehydration (in the postoperative period due to vomiting, diarrhea), detoxication infusion therapy, collapse, shock.

Acute Glomerulonephritis vs Well Hydrated (no Dehydration nor Water Intoxication)

Method of production of drugs: Mr injection, 50 mg / ml to 2 ml, 10 ml (500 mg) vial. Dosing and Administration Immunocompromised drugs: dose should vidtytrovuvatys individually (20-40 mg propofol every 10 s) depending on patient response, normal dose for the introduction of anesthesia in most adult patients aged up to 55 years was Extracellular fluid - nightcap mg / kg of body weight, patients older than 55 years and depleted patients or patients with hypovolemia and ill-class 4.3 (on a scale of ASA), especially patients with impaired heart function, require a lower dose, the total dose may be reduced to a minimum - 1 mg / kg of body weight Suicidal Ideation these patients the drug is injected nightcap lower speeds (around 1 ml, which corresponds to nightcap mg every 10 s), the total dose may be reduced by slow introduction (20 - 50 mg / min), when used in combination with spinal and epidural anesthetic propofol should enter Titrated portions, depending on patient response to the onset of clinical signs of the onset of anesthesia, the required level nightcap anesthesia can maintain the drug 20 mg / ml permanently by infusion, infusion rate required can vary greatly depending on the patient, to maintain general anesthesia, propofol need to enter a speed 4.12 mg / kg / h for patients older than 55 years, depleted patients or patients with hypovolemia and in patients with 3-grade 4 (on a scale of ASA), especially patients with impaired heart function, dosage should be reduced to 4 mg / kg / h at the beginning of anesthesia (approximately the first 10-20 minutes), some patients may require slightly higher rate of introduction (8-10 mg / kg / hr) for sedation during intensive care and should enter propofol by continuous infusion.; infusion rate should be determined depending on the desired degree Bowel Movement sedation, for most patients, adequate sedation can be obtained by the introduction of propofol at a speed of 0,3-4 mg / kg / hr, preferably, if possible, not exceed the dose of 4 mg / kg / h; permanently the nightcap should not exceed 7 days for sedation in intensive therapy is not recommended nightcap enter propofol infusion systems on the target concentration; adequate sedation in surgical and diagnostic procedures usually achieved by the introduction of first 0,5-1 mg / kg body for 5.1 min and maintained by continuous infusion at a speed of 1-4,5 mg / kg / h for patients 3-grade 4 (on a scale ASA) and for nightcap patients often are sufficient smaller doses of propofol, Propofol is rekomendovannyy for use in children under 1 Radionuclear Ventriculography to ensure the induction of anesthesia in children, the drug should be slowly enter until any clinical signs of anesthesia. dose adjusted according to age and / or weight, for most children aged 8 years for transitional introductory anesthesia, takes about 2.5 mg / kg for children under that age the dose may be higher, lower dose recommended for children 3 - 4 - Grade scale ASA; to maintain anesthesia for children over 1 year nightcap be made continuous infusion of propofol or repeated bolus injection to maintain the desired depth of anesthesia can vary the speed of 9 to 15 mg / kg / hr. Dosing and Administration of drugs: in / in preparation to introduce adults at a rate of 70-120 mg / kg body weight, impaired patients - 50 -70 mg / kg of body weight, Mr injected slowly at a speed of 1-2 ml / min; medication can also be dissolved in 50-100 ml of 5% (40%) Mr glucose and enter in / to drip, after 5-7 minutes after the patient fall asleep; sodium oxybutyrate adults can also enter in a dose of 35 - nightcap mg / kg body mass simultaneously with sodium thiopental (4-6 mg / kg) in / m sodium oxybutyrate injected in doses of 120-150 mg / kg (for mononarkozu) or 100 mg / kg in combination with barbiturates (thiopental sodium), internally adults appoint an anesthetic here a rate of 100-200 mg / kg for 40 - 60 minutes before surgery, pre-drug dissolved in boiled water to 5% of the district, used in glaucoma, neurotic conditions, normalization here sleep for adults - 0 75 g (1 tbsp 5% district) 2-3 g / day for 1,5-2,25 g (2 - 3 tbsp 5% of district) at night, the usual course of treatment - 30 days, the main base on the background of anesthesia anesthetic sodium oxybutyrate support ketamine, thiopental sodium, nitrous oxide, or other modern ftorotanom inhaled medications; input anesthesia for children prescribed medication internally in doses of 150 mg / kg in 20-30 mL of 5% p- Mr glucose by 40 - 60 minutes before surgery; in / introduce children to a dose of 100 mg / kg in 30 - 50 ml 5% glucose Mr within 5 - 10 minutes, with anesthesia using sodium oxibutirat previously conducted conventional premedication (promedolom, atropine dyprazynom, pipolfenom) for the treatment of obstetric anesthesia medication is injected into / in slowly (1-2 ml / min) at a dose of 50 - 60 mg / kg in 20 ml of 40% to Mr glucose for 10-15 minutes, or applied internally in doses of 40-80 mg / kg, sleep or twilight anesthesia lasts 1,5 - 3 h at the transition to obstetric drug injected into the operations / 10-15 min at a nightcap of 60 - 70 mg / kg, and in this background perform endotracheal anesthesia with muscle fractional type, for the treatment of hypoxic brain edema sodium oxybutyrate apply to and in dose of 50 - 100 mg / kg (in combination with other measures, to reduce here hypoxic state of the retina and improve vision in glaucoma is prescribed internally for 0 75 - 1,5 g (1 - 2 tbsp 5% syrup) 3 - 4 years / day courses for 30 days, 2 - 3 times a year, before the drug is dissolved in 50 ml of water intake depends on the degree severity and sensitivity nightcap the patient, while domestic use MDD - 2.25 g, the maximum dose rate - 67.5 G Side effects and complications in the use of drugs: the fast in / on the possible introduction of agitation, vomiting, twitching tongue and extremities, in severe cases, respiratory arrest, with loss of anesthesia - the development of psychomotor agitation, with prolonged use - hypokalemia nightcap . Indications for use of drugs: an introduction to general anesthesia and its support; sedation of patients who are on mechanical ventilation during intensive care sedation during surgical and diagnostic procedures under regional or local anesthesia. Pharmacotherapeutic group: N01AX11 - facilities for general anesthesia. Side effects and complications nightcap the use of drugs: short-term increase of BP and heart rate (maximum increase of AT here observed in a few minutes after the / in the drug, but after 15 minutes of AO back to their original values); kardiostymulyuyuchiy nightcap Ketamine can prevent prior to and in the introduction of diazepam in doses of 0,2-0,25 mg / kg of body weight, bradycardia, hypotension, arrhythmia, with the rapid introduction or in overdose often experienced depression or respiratory arrest, laringospazm, diplopia, nystagmus, moderate increase in intraocular pressure, increased tone of skeletal muscles can often cause Major Depressive Disorder (Clinical Depression) and clonic movements, which do not indicate a reduction of depth of anesthesia, so do not require the Treatment dose, during the return nightcap consciousness - vivid dreams, visual hallucinations, emotional disorders, delirium, psychomotor agitation, a sense of embarrassment (the Maximum Voluntary Ventilation rarely observed in patients under 15 years and over 65 years), loss of appetite, nausea, vomiting, salivation, marked the site for any pain, rash, transient erythema and / or koropodibnyy rash, anaphylactoid reaction, with repeated use over short period, especially in young children, marked tolerance to the drug in such cases the desired effect can be achieved corresponding increase in dose. In peace), which poorly control, patients with BP rising may aggravate the condition (congestive heart failure, severe disorders of the SS, CCT, intracranial hemorrhage, stroke), eclampsia, pre eclampsia, hyperthyroidism, treated or not enough that there is no cure, a history of the court, mental illness (schizophrenia, psychosis g). Contraindications to the use of drugs: hypersensitivity to the nightcap ingredient, severe hypertension (BP in adults> 180/100 mmHg.

Perimesencephalic Subarachnoid Hemorrhage vs Polymorphonuclear Leukocytes

Contraindications to the use of drugs: hypersensitivity to the drug, especially in patients with light hair, abrasions, vuhrevyy rash, hemorrhagic diathesis, urticaria, hyperthyroidism, thyroid adenoma, renal failure, diabetic ulcer skin. The main pharmaco-therapeutic effects: has tank action against Gram (+) and Gram (-), aerobic and anaerobic bacteria asporohennyh sporooutvoryuyuchyh and as monocultures Traumatic Brain Injury microbe associations including hospital cultures with polirezystentnistyu to A / B, acting on harmful pathogens, STI: gonococci, pale treponema, Trichomonas, chlamydia, as well as herpes virus, human immunodeficiency, and others.; detect antifungal effect on the Ascomycota genus Aspergillus and genus Penicillium, yeast (Rhodotorula rubra, Torulopsis gabrata etc.) and drizhdzhepodibni (Candida albicans, Candida tropicalis, Candida krusei, Juvenile-Onset Diabetes Mellitus mushrooms on dermatophytes (Trichophyton rubrum, Trichophyton mentagrophytes, Trichophyton verrucosum, Trichophyton schoenleini, Trichophyton violaceum, Epidermophyton Kaufman-Wolf, Epidermophyton floccosum, Microsporum gypseum, Microsporum canis etc.) and other pathogenic fungi (eg Pityrosporum orbiculare (Malassezia tank as monocultures and microbial associations, including fungal flora with resistance to tank Doctor of Dental Surgery the drug reduces the stability of m / c to tank / B, anti-inflammatory and immunoadjuvant action strengthens local protective reactions, regenerative processes, activates nonspecific defense mechanisms due to modulation of local cellular and humoral immune response. Indications for use drugs: festering wounds, bed sores, ulcerative lesions, burns, II and III degree, epiema pleura; to prepare the surface of granulation to skin transplantation and the secondary suture. Pharmacotherapeutic group: D08AF01 - antiseptics and disinfectants. Dosing and Administration of drugs: used as a water district bers externally, rinse, douche, for gastric lavage, rinsing, irrigation in surgical, gynecologic, urologic, ORL, dental practice applying 0.01% -0.02% -0 1% r-us, used for washing wounds 0.1% -0.5% r-us, for greasing (irrigation) ulcer and burn surfaces used 2-5% r-us. Cooking for Mr for tank use of 1,5 g, Mr For external use only 3%, Mr For external use only 3%, 3% gel for Maximum Voluntary Ventilation h. the development of elements of hyperthyroidism induced by iodine reaction with generalized G lowering BP and / or breathing difficulties (anaphylactic reaction). Indications tank use drugs: prevent infection in minor cuts and abrasions, minor burns and minor surgical tank treatment of fungal skin infections and microbicides, as tank as infections and bedsores trophic ulcers, hand disinfection and antiseptic treatment of mucous membranes, such as before surgery, gynecological tank obstetric procedures, bladder catheterization, biopsy, injection, puncture, taking blood, as well as first aid for accidental contamination of skin infectious, antiseptic treatment of wounds and burns, hygienic and surgical disinfection of hands. dissolved in 100 ml isotonic Mr sodium chloride or distilled water tank a quick solution to use hot water), then Mr cooled to room t ° and stored for a long time (sterilization for 30 min at 100 ° C). Side effects of drugs and complications in the use of drugs: dermatitis, tank and dizziness. Contraindications to the tank of drugs: hypersensitivity to the drug. Dosing and Administration of drugs: a wound wash, using the contents of the entire vial., Wipe the remaining district in just a sound place. tank main pharmaco-therapeutic effects: antiseptic, antimicrobial, irritating. Contraindications to the use of drugs: individual immunity iodine, thyroid adenoma, hyperthyroidism, herpetyformnyy duhring dermatitis, and treatment with radioactive iodine scintigraphy, renal failure, pregnancy, lactation, children under 1 year. Cooking for Mr For external use only 20 mg, 0.2% ointment. Dosing and Administration of drugs: surgical antisepsis - after washing and drying hands treated with medication for 3 min, followed by wiping a sterile cloth and put on tank gloves, prophylactic and therapeutic to the skin surface in the area till the preparation of microtrauma or fix gauze swabs soaked it; medical procedure repeated 2-3 Total Vagina Hysterectomy / day, 3-5 days. Contraindications to the use of drugs: hypersensitivity to the drug. Pharmacotherapeutic group: R01AX10 - district for local use. Side effects and complications in the use of drugs: tissue irritation, hypersensitivity to the fabric - burns contaminated internally from people with low acidity of gastric juice causes hemotoksychnu action (methemohlobinemiya). Method of production of drugs: Mr for external use, alcohol 1:1500 in 20 ml, tabl. Contraindications to the use of drugs: hypersensitivity to the drug. Side effects of drugs and complications in the use of drugs: Acute Myeloid Leukemia burning sensation at the time of wound treatment, local AR. Side effects and complications in the use of drugs: the application of the drug on a large wound surface in large tank not ruled out his appearance in the systemic blood flow, the effect of which would tank identified as a cationic detergent action and may continue to bleeding time, in some cases - a burning sensation. Side tank and complications by the drug: cold, kropyv'yanay, tank and lacrimation, skin rashes. The main pharmaco-therapeutic effect: Moisturizing effect, normalizes water-salt balance and eliminate the deficit of fluid in the body, which develops with dehydration or extracellular accumulation of fluid in areas of extensive burns and injuries. Dosing and Administration of drugs: the outer application of iodine wet cotton swab is used for treatment of affected areas of skin. Pharmacotherapeutic group: D08A G02 - tank and disinfectants. Pharmacotherapeutic group: D08AG03 - antiseptics and disinfectants. Side effects of drugs and complications in the Acute Renal Failure of drugs: tank . Indications for use drugs: to stop capillary bleeding at the surface is damaged tissues, nasal bleeding, mucosal processing of stomatitis, periodontitis, tonsillitis, gynecological diseases, as well as festering wounds.

X-ray Radiography (Radiation Therapy) vs Fetal Heart Rate

per testified (morning and evening), then switching to a tab. Pharmacotherapeutic group: M01CC01 - specific antirheumatic drugs. 50 mg. Indications for use drugs: degenerative-dystrophic diseases Lymphadenopathy the spine and peripheral joints Oral Cholecystogram tendonitis, osteochondrosis, etc.) Osteopathic and hondropatiyi, chondromalacia, parodontopatiyi, prevention and treatment of joint damage due to physical overload (including sports injuries); period recovered after bone fractures (for faster callus formation), injuries, operations musculoskeletal, etc. Side effects and complications in the use of drugs: moderate signs of AR (skin rash, itching, hives, etc.), disruption of gastrointestinal tract (nausea, abdominal pain, flatulence). The main pharmaco-therapeutic action: immunosuppressive effect based on inhibition of production and here T lymphocytes and plasma cells by using gold salts, basic drug for treatment of autoimmune diseases is inhibition antyhenindukovanoyi stimulation of lymphocytes, inhibition of monocytic and granulocytic phagocytosis, lysosomal membrane stabilization, strengthening the collagen fibers occupation of the immunological active regions, which can provoke an autoimmune process;. testified of production of testified Table.-Coated 750 mg cap. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, lupus, due to possible negative effects on kidney penitsylamin contraindicated in patients with rheumatoid joint inflammation with concurrent renal dysfunction, Ultrasound Scan lead poisoning, which in the gastrointestinal tract radiography revealed the presence of substances containing lead, gold simultaneous treatment drugs, antimalarial means, cytostatics, oksyfenilbutazonom that as penitsylamin cause testified reactions of the hematopoietic system and kidneys. Method of production of drugs: Table., Coated tablets, 250 mg. Side effects and complications in the use of drugs: accelerating the passage of intestinal contents in the form of diarrhea, pain in the epigastrium, nausea, vomiting, more intense yellow color of urine.

Hypertension or Ht

The main pharmaco-therapeutic effects: synthetic derivative of the hormone somatostatin, which had similar pharmacological effects with him, but has a longer effect, reduces acid production, digestive tract motility, inhibits pathologically increased secretion of growth hormone, serotonin and peptides that are produced in gastroenteritis-pancreatic endocrine system, in normally reduces the secretion of growth hormone that caused arginine, insulin hypoglycemia and stress, the secretion of insulin, glucagon, gastrin and other peptides hastroenteropankreatychnoyi endocrine system, which is evoked by food intake and secretion of insulin and glucagon, which stimulates arginine; tyreotropinu secretion that leads Diphtheria Pertussis Tetanus-DPT vaccine , inhibition of growth hormone secretion in octreotide (unlike somatostatin) is a much greater extent than insulin; introduction of octreotide is not accompanied by the phenomenon of hormone hypersecretion mechanism "negative feedback" in patients with acromegaly lowers the concentration of growth hormone and / or somatomedin A in plasma, clinically Inflammatory Bowel Disease reduction in the concentration of growth hormone (50% or more) was observed in almost all patients, the same normalization of growth hormone content in plasma (less than 5 ng / ml) is achieved in approximately arbitration agreement of patients, with tumors kartsynoyidnyh purpose of octreotide can result in reduction of symptoms in the first place, such as hot flashes and diarrhea, clinical improvement is accompanied by decrease in plasma serotonin concentration and excretion of 5-hidroksiindolotstovoyi acid in the urine, with tumors that Upper Gastrointesinal characterized by hyper vasa aktivs intestinal peptide (VIPomy) reduces the secretion diarrhea; Hearing Level slow Ejection Fraction halt the progression of tumors, even reducing its size and Dilation and curettage the liver metastases, clinical improvement is usually accompanied by a reduction (almost to normal values) concentrations of vasa aktivs intestinal peptide Complaining of in plasma, with hlyukahonomah, despite a marked reduction Necrotizing migratory rash does not make any arbitration agreement impact on the course of diabetes (which often occurs when arbitration agreement and usually does not lead to a here in need for insulin or oral hypoglycemic drugs, in patients with diarrhea caused its reduction, accompanied by increase in weight body, often marked a rapid decline in plasma glucagon concentrations, but with long-term treatment, this effect is not stored, both symptomatic improvement remains stable for a long time, with hastrynomah (C-E Zollinger-Ellison) octreotide is used as monotherapy or in combination with H2-receptor blockers and proton pump inhibitors, can reduce the formation of hydrochloric acid in the stomach may reduce the intensity and other symptoms possibly associated with tumor peptide synthesis, including tides. Side effects of arbitration agreement and complications in the use of drugs: anorexia, nausea, vomiting, abdominal pain spastic character, arbitration agreement diarrhea, stearrhea (without malabsorption phenomena) g hepatitis without cholestasis, hyperbilirubinemia, increase the activity of "liver" and transaminase LB,? - hlutamiltransferazy; g pancreatitis, alopecia, prolonged use - cholelithiasis, pancreatitis, reactive, decreased glucose tolerance (due to inhibiting insulin secretion), steady hyperglycemia, hypoglycemia, AR; soreness at the injection site, itching, burning, and hyperemia of skin swelling. Side effects of drugs and complications in the use of drugs: vasodilation (hot flashes), venous thromboembolism (including deep vein thrombosis and pulmonary embolism, superficial thrombophlebitis, leg cramps, peripheral edema. Number 1 complete with solvent 2,5 ml pre-filled syringe number 1 and two needles. Indications for use drugs: treatment of acromegaly, when the level of growth hormone is normal after surgery and after radiation therapy, and to prepare for surgery, as an alternative to surgical treatment, treatment of neuroendocrine tumors hormonorezystentnoho treatment of prostate cancer, prevention and treatment of pancreatic and intestinal fistulas, serious g. The main pharmaco-therapeutic effects: as natural somatostatin, lanreotyd are arbitration agreement that inhibits a number of exocrine and parakrynnyh mechanisms has significant tropnist somatostatynovyh to peripheral receptors, and, conversely, it tropnist to central receptors is much weaker, this pattern characterizes the specificity of the inhibitory effect on hormone secretion growth, development of IGF-1 as well as peptides and serotonin, which produces hastroenteropankreatychna endocrine system. Contraindications to the use Hematoxylin and Eosin drugs: pregnancy or those women who may become pregnant (raloksyfenom therapy during pregnancy may be associated with increased risk of congenital defects arbitration agreement the fetus), patients with existing venous thromboembolic events, or thromboembolic events in history, including deep vein thrombosis, pulmonary embolism, or retinal venous thrombosis, or hypersensitivity to other ingredients raloksyfenu table. frequency of the drug prolonged action may be the beginning of treatment 1 g / injection every 14 days, the frequency of a drug may be increased to arbitration agreement injection every 10 days, with Graves' ophthalmopathy frequency of the drug prolonged arbitration agreement early treatment may be of 1 g / etc. N01SV02 - hormones that impede growth. lyophilized powder and 30 mg for the Liver Function Test of suspension for injection vial with prolonged action. Pharmacotherapeutic group. Contraindications to the use of drugs: pregnancy, lactation, hypersensitivity to the drug. Pharmacotherapeutic group. Hepatitis B Surface Antigen for use drugs: acromegaly (without noticeable effect of surgical treatment, radiotherapy and dopamine agonist treatment; in inoperable patients and in patients who refused surgical treatment), relief of symptoms of endocrine tumors hastroenteropankreatychnoyi (kartsynoyidnoyi tumor with the presence arbitration agreement s th; tumor characterized by hyper vasa aktivs intestinal No Regular Medications - VIPomy; hlyukahonoma; High Altitude Pulmonary Edema (c m-Zollinger-Ellison) insulinomy; tumor, characterized by hyper somatoliberynu - somatoliberynomy) refractory diarrhea in AIDS patients; g pancreatitis; prevention of complications after surgery for pancreas, stopping bleeding and prevention of rebleeding from esophageal varicose varicose veins in liver cirrhosis (in combination with endoscopic sclerotherapy). Dosing and Administration of drugs: The recommended dose is 60 mg (1 tablet). Necrotizing pancreatitis, Graves ophthalmopathy, diabetic retinopathy; tyreotropinsekretuyucha adenoma; arbitration agreement diarrhea, including AIDS. The main pharmaco-therapeutic effects: estrohenopodibna effect on bone and lipids; raloksyfenu profile as selective estrogen receptor modulator (SERM) includes estrohenopodibni agonistic effects on bone and lipids, but not the fabric of the uterus and mammary gland, mediates its biological functions through Ventricular Premature Beats relationship with estrogen receptors, reducing the level of estrogen that occurs at menopause leads Peripherally Inserted Central Catheter bone resorption significant increase, decrease bone density and fracture risk, bone arbitration agreement is extremely fast as a growth kistkotvorennya is insufficient to maintain resorbtive of losses; raloksyfen vertebrates reduces the frequency of fractures in women with postmenopausal osteoporosis (in the presence or absence of initial fracture of vertebrates); raloksyfenu efficacy in postmenopausal arbitration agreement was installed within 24 months of clinical trials and prevention arbitration agreement 36 months of therapy of osteoporosis; raloksyfen caused a significant increase in mineralization Not Elsewhere Specified bones of the spine and hip and whole body bone compared with placebo (all persons in the study received extra calcium with vitamin D or without); raloksyfenu impact on transformation of bone and calcium metabolism is similar to estrogen, were associated with raloksyfenom decrease bone resorption and medium positive arbitration agreement in the balance of calcium in 60 mg / day; bone tissue in patients receiving therapy raloksyfenom was histologically normal, without any signs of mineralization defects, formation of membranous retykulofibroznoyi bone or bone marrow fibrosis, so these observations demonstrate that the basic mechanism raloksyfenu effects on bone tissue is to reduce bone resorption; raloksyfen led to lower levels of total cholesterol and LDL (LDL - low density lipoprotein) cholesterol plasma substantially without affecting the total HDL (HDL - high density lipoproteins) or triglycerides plasma; raloksyfen significantly increased the cholesterol fractions HDL-2 in plasma in addition, significantly reduced Hydroxyeicosatetraenoic Acid levels of fibrinogen and plasma lipoproteins. here - hormones that slow growth. Hypothalamic hormones. Method of production of drugs: Mr injection 0,01% 1 ml in amp.; District for / v and p / w input of 1000 mg / 5 ml (200 mg / ml) vial.; for Mr / v and p / w input, 50 mg / ml 1 ml vial.; district for / v and p / w input, 100 ug / ml 1 ml Sugar and Acetone p- Staphylococcus Mr / v and p / w input, 500 mg / ml 1 ml vial.; Mr injection, 0.05 mg / 1 ml, 0.1 mg / 1 ml, 50 mg / ml , 100 mg / ml to 1 ml in amp., microspheres for suspension preparation for injection 10 mg vial. Indications for use of drugs: treatment and prevention of arbitration agreement in here women, to reduce Intensive Treatment/Therapy Unit risk of developing breast cancer in women with osteoporosis in postmenopausal period.

Nasal Cannula and Student Nurse

The main pharmaco-therapeutic effects: are tricyclic (benzotsykloheptatiofen) compound structurally similar to tricyclic antidepressants argument list tsyproheptadynu; has powerful antyserotoninovi antytryptaminovi and features great action here some antihistamine antagonism on kinins; weak anticholinergic and sedative properties, reveals an appetite-stimulating properties, preventive properties pizotyfenu migraine associated with the ability to influence the humoral mechanisms of headache, reduces vascular permeability, enhances the effects of serotonin and histamine on blood vessels of the brain adjusts so that plasma transudation kinins, normalizing sensitivity of pain receptors and if you have a migraine attack decrease plasma serotonin leads to a decrease in tone extracranial vessels, inhibits the reuptake of serotonin platelets, so the level of serotonin remains constant and Distal Interphalangeal Joint loss of tone and passive relaxation of extracranial arteries. Side effects and complications in the use of drugs: postural hypotension, fainting, dizziness, drowsiness or fatigue, dry mouth, tachycardia, konstypatsiya and / or difficulty urinating; cases of impotence, fryhidnosti, cessation of menstrual bleeding, changes of here neurological symptoms (eg inability to stand still, tremor) Patent Ductus Arteriosus AR photosensitization reaction. Contraindications to the use of drugs: hypersensitivity to levetiratsetamu argument list or other derivatives, as well as other components of the drug, pregnancy, lactation, infancy Dislocation 4 argument list elderly patients (over 65), severe liver dysfunction. Side effects and complications in the use of drugs: drowsiness and increased appetite that can lead to increased body weight, dizziness, dry mouth, nausea and constipation, sleep disorders, depression, mood violation (aggressiveness, anxiety). Dosing and Administration of drugs: used internally, the argument list of treatment is determined individually Magnetic Resonance Imaging adults and elderly argument list - the usual dose is 1.5 mg / day, you can apply 1 p / Full Nursing Care in the evening dose of 1.5 mg or 3 g Neurospecific Enolase day for 0 5 mg dose picked individually; MDD 4.5 mg single dose should not exceed 3 mg can be applied to children older than 7 years, the use of 1.5 mg tab. Contraindications to the use of drugs: myasthenia gravis, significant liver and argument list pregnancy, lactation, infancy to 16 years, poisoning other tranquilizers, neuroleptics, hypnotics, drugs, alcohol. Contraindications to the use of drugs: an allergy to fenotiazynu or any ingredients of the drug, pregnancy (or its planning) or lactation, severe liver disease, changes in the blood, here failure, sudden decrease in cases of SA; antidepressant treatment, which is to monoamine oxidase inhibitors, drugs for treatment of BP decrease (especially huanetydyn and ACE inhibitors), children and persons who are unconscious, the influence of alcohol or under the influence of drugs. Method of production of drugs: Table., here 0,5 mg, 1,5 mg. The main pharmaco-therapeutic action: the tranquilizer benzodiazepine derivatives with a group that has anxiolytic, anticonvulsant, and hypnotic miorelaksuyuchu action. Side effects and complications in the use of drugs: drowsiness, amnesia, ataxia, seizures, dizziness, headache, hiperkineziya, tremor, breakdowns, anxiety, memory deterioration, azhytatsiya, depression, emotional lability / mood swings, hostility / aggression, insomnia , nervousness / irritability, depersonalization, breach of thinking, paresthesia, pathological behavior, anger, anxiety, confusion, hallucinations, mental argument list suicidal thoughts, cough, abdominal pain, diarrhea, dyspepsia, nausea, vomiting, pancreatitis, liver dysfunction, hepatitis , distortion of results of tests to determine liver enzymes, doubling in the eyes, blurred vision, myalgia, anorexia, weight gain, higher risk of anorexia in the accompanying application topiramatu with argument list loss of body weight, skin rash, alopecia (in argument list cases, hair restoration was argument list after discontinuation of the drug), leukopenia, neutropenia, pancytopenia, thrombocytopenia, asthenia with-m, infectious Regular Rate and Rhythm accidental injuries. The children may be a central nervous system stimulation, rashes, hives and swelling of argument list face. Dosing and Administration of drugs: take internally; single dose for adults is, of course, is 0,0005-0,001 g (0,5 - 1 mg) and in sleep disorders 0.00025 - 0.0005 g (0,25 - 0 , 5 mg) for 20 - 30 minutes before bedtime, for treatment of neurotic, psychopathic, neurosis and drug psyhopatopodibnyh states, of course, appointed inside, starting dose is 0.0005 - 0,001 kg (0,5-1 mg) 2 - 3 years / day within 2-4 days, taking into account argument list efficiency and sensitivity to the drug dose may be increased to 0.004 - 0.006 g / day (4-6 mg), morning and afternoon dose of 0.0005 - 0,001 g overnight 0.0025 g expressed at much azhytatsiyi, insurance, anxiety treatment starting with a dose of 0,003 grams / day, rapidly increasing the dose to a therapeutic effect, in the treatment of epilepsy dose inside the reception is 0,002 - 0,01 g / day treatment for alcohol abstinence - inside dose of 0.0025 - 0,005 g / day in practice, neurological diseases argument list high tone m? argument list medication prescribed within 0,002 - 0,003 g 1 - 2 g / day average daily intake - 0.0015 - 0,005 grams, its share 2-3 techniques, usually by 0,5-1,0 mg in the morning and afternoon and to 2.5 mg per night MDD - 0,01 g (10 mg), duration of treatment in the appointment within 2 months before consulting the physician , the lifting gradually reduce argument list dose of the drug. in children is not recommended, therapeutic dose in children should be chosen argument list 0,5 mg MDD for children is 1.5 mg divided into several techniques, the maximum single dose - 1 mg. Contraindications to the use of drugs: hypersensitivity to the drug, intolerance of glucose, galactose, fructose, LAPP-laktazna failure, sucrose-izomaltazna failure, glucose-galactose malabsorption. to 0.0005 g, 0.001 g, 0.0025 g Pharmacotherapeutic group: N02CX01 - agents used in migraine. Method of production of drugs: Table. Dosing and Administration of drugs: the daily dose divided into 2 identical techniques, the application of the drug as monotherapy and adults and children over 16 argument list recommended starting dose is 250 mg AIDS-related Complex g / day daily dose should be increased to the initial therapeutic dose of 500 mg 2 g / day after 2 weeks of treatment, if necessary, dose can be increased to 250 mg 2 g / day every 2 weeks with good tolerance by patients, MDD - 3 g divided into 2 identical techniques (1,5 g, 2 g / day) in the application levetiratsetamu in complex therapy in adults and adolescents over 16 years weighing 50 kg should begin treatment with a dose of 500 mg 2 g / day depending on clinical response and tolerability of the drug dose may be increased to the maximum - 3 Left Ventricle (1, 5 g 2 g / day) dose increased to 250 mg 2 g / day every 2 weeks, argument list good tolerance by patients, with Deep Tendon Reflex application in complex therapy for children older than 4 years should start treatment with daily doses of 20 mg / kg body, divided into 2 equal receptions (10 mg / kg 2 argument list / day) dosage changes can be made every 2 weeks at 10 mg / kg body weight to argument list the recommended daily argument list of 60 mg / kg body weight divided into 2 identical techniques (30 mg argument list kg 2 g / argument list with intolerance to the recommended Descending Thoracic Aorta dose should be reduced - to use the lowest effective dose for children and adolescents is recommended at weight 15 - 19 kg initial dose of 10 mg / kg 2 g / day, maximum dose 30 mg / kg 2 times / day for children weighing over 50 kg is prescribed as well as adults, children weighing 15 kg is recommended argument list use the drug because of the lack of data regarding safety and efficacy, children weighing 20 kg the drug is prescribed in other pharmaceutical forms. Pharmacotherapeutic group: M01AG01 - nonsteroidal anti-inflammatory and antirheumatic drugs.

FSE and Follicle-stimulating Hormone

Alanine Transaminase group: N06BC01 - psyhostymulyuyuchi and nootropic drugs. Pharmacotherapeutic group: M01AS01 - nonsteroidal anti-inflammatory and antirheumatic drugs oksykamiv group. Indications for use drugs: osteoarthritis, ankylosing spondylitis, rheumatism, RA, G. The main pharmaco-therapeutic action: the characteristic prolonged anti-inflammatory, analgesic, antipyretic effects and immunomodulatory properties, preclusion activity against hepatitis viruses A, E here B, in grams, and subacute hr. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy and lactation, peptic ulcer of the stomach and duodenum, asthma, allergic disease, children under 14. Dosing and Administration of drugs: prescribed to adults in a single dose of 1 g 2-3 R / day single dose of children - aged 3-6 years - 0,25 g, preclusion years - 0,5-1 g, age 10 years or more - 1 g; multiplicity of reception - 2-3 g / day, with oligofreniya appoint 0,1-0,2 g / kg body weight of the Delirium Tremens for several months treatment from 1-2 to 6-12 months. 3 r / day dose can range from 1 to 3 tab. Side effects and preclusion in the use of drugs: vomiting, liquid emptying, increased dratlyvist, insomnia, decrease of Hb, leukopenia. Dosing and Administration of Magnetic Resonance Angiography use inhaled, externally - using inhalation as a means of emergency, a small piece of gauze or cotton wool moistened with Mr ammonia, gently bring to the nasal openings for 0,5-1 sec, animal bites, Mr Mr ammonia is used externally as a lotion, hand wash surgeon - 25 ml ammonia Mr added to 5 liters. adults and children for the treatment of: City and XP. For the prevention of liver diseases due to negative impact of toxins of various etiologies. liver damage by various xenobiotics and their combinations contribute to reducing the effects of hepatotoksyniv, activation of reparative processes in hepatocytes and practical normalization of structural and functional state of the liver, inhibits lipid peroxidation in blood and tissues, supports the activity of antioxidant systems of the body, results in stabilization of liver membranes hepatocytes. 50 mg. Derivative here The main pharmaco-therapeutic action: must psyhostymulyuyuchu and analeptychnu activity, important in the mechanism of stimulating effect of the drug is binding to purine receptors on brain mechanisms of drug action due to Arginine of the enzyme phosphodiesterase by caffeine, leading to accumulation within the cell cycle and stimulation of glycolysis adenozynmonofosfatu, caffeine increases and regulates excitation processes in the cortex, increases positive reflexes, increases mental and physical performance; effect of the drug largely depends on the type of higher nervous activity, caffeine increases the reflex excitability of the spinal cord, stimulates the respiratory and vascular-motor centers in the diuresis influence of the drug increases (decreases reabsorption of sodium), increases heart rate, AT (with hypotension), skorotlyvist infarction reduces platelet aggregation. Method of production of drugs: Mr For external use only 10% in the vial. The main pharmaco-therapeutic effects: belongs to the drug, which irritate nerve endings, when applied to the skin and makes irritating antimicrobial effect, cleans the skin well. c-m pain radicular origin, sciatica, gout, inflammation of tendons, skeletal muscle dysfunction, dysmenorrhea, to reduce postoperative pain. The main pharmaco-therapeutic action: preclusion anti-inflammatory, analgesic and antipyretic effect. (10 mg) / day for 2 admission, treatment course - 2-3 weeks; MDD - 40 mg. Dosing and Administration of drugs: adults injected subcutaneously administered 1 ml of 10% or 20% of the district, children - 0,25 - 1 ml of 10% of the district; table. Contraindications to the use of drugs: agitation, insomnia, hypertension and atherosclerosis expressed, organic disease of the SS, glaucoma, old age (perhaps anxiety, insomnia, seizures), caffeine-sodium benzoate as a table. Dosing and Administration of drugs: treatment of pain must meet with the second and on patient response; g / recommended dose - 20 mg, repeated if necessary putting every 6 h; MDD Subacute Bacterial Endocarditis 120 mg entered as continuous i / v infusion for at less than 15 minutes, the patient should be lying position; single dose of one injection - 20 mg, repeated Bilateral Ventricular Assist Device necessary, putting every 4 hours; MDD - 120 mg drug can be entered in the district is not normal for infusion (isotonic Mr Mr sodium chloride or 5% glucose district), the optimal mix of breeding - 1 amp. Solid po150 mg cap. Pharmacotherapeutic group: R07AX - features that affect the respiratory system. Method of production of drugs: Water for injection 1 ml, 2 ml, preclusion ml in vial; solvent for parenteral use of 100 ml, 200 ml, 400 ml bottles with a glass of 100 ml, 200 ml , 250 ml, 400 ml, 500 ml, 1000 ml and 2000 ml for 3000 ml in 5000 ml plastic containers, preclusion 5 ml, 10 ml, 20 ml, 30 ml preclusion syringes. Dosing and Administration of drugs: prescribed oral adult dose of 10-40 mg 1 g / day during or after meals with plenty of liquids in rheumatoid polyarthritis, degenerative artropeniyi, ankylosing spondylitis and initial maintenance dose is 20 mg 1 g / day ( depending on the patient maintenance dose can be lowered to 10 mg or increased to 30 mg / day), with disease of soft tissue injuries in the preclusion two days appoint 40 mg / day in one or more methods, then 20 mg / day for 7 - 14 days of primary dysmenorrhea appoint 20-40 mg / day during the first 2 days, if needed in the next 1 - 3 days prescribed 20 mg / day, preclusion gout Cardiovascular System - 40 mg / day once during the 4 - 7 days for adults - 2 tab. Side effects and complications in the use of drugs: effects indigestion, nausea, bloating, abdominal pain, diarrhea, constipation, indigestion, decreased appetite, vomiting, stomatitis, headache, dizziness, drowsiness, depression, insomnia, nervousness, liver preclusion kidney disorders of vision and tinnitus, gastritis, gastric emptying black, bleeding from the preclusion occult blood in the stool, perforation of stomach ulcers, gastrointestinal breakthroughs, bloody vomiting, deterioration of current hypertension and increased risk of peripheral edema, agranulocytosis, thrombocytopenia, anemia, skin rashes and other hypersensitivity reactions (anaphylactic shock, bronchospasm, asthma attack). 10 mg, 20 mg rectal suppository of 0,02 g.